Gemcitabine-(5'-phosphoramidate)-[anti-IGF-1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549)

about

Gemcitabine-(5'-phosphoramidate)-[anti-IGF-1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549)

Item

http://www.wikidata.org/entity/Q33578254

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Gemcitabine-(5'-phosphoramidat ...... ulmonary adenocarcinoma (A549)

@ast

Gemcitabine-(5'-phosphoramidat ...... ulmonary adenocarcinoma (A549)

@en

Gemcitabine-(5'-phosphoramidat ...... lmonary adenocarcinoma (A549).

@nl

type

Item

label

Gemcitabine-(5'-phosphoramidat ...... ulmonary adenocarcinoma (A549)

@ast

Gemcitabine-(5'-phosphoramidat ...... ulmonary adenocarcinoma (A549)

@en

Gemcitabine-(5'-phosphoramidat ...... lmonary adenocarcinoma (A549).

@nl

prefLabel

Gemcitabine-(5'-phosphoramidat ...... ulmonary adenocarcinoma (A549)

@ast

Gemcitabine-(5'-phosphoramidat ...... ulmonary adenocarcinoma (A549)

@en

Gemcitabine-(5'-phosphoramidat ...... lmonary adenocarcinoma (A549).

@nl

P1476

Gemcitabine-(5'-phosphoramidat ...... ulmonary adenocarcinoma (A549)

@en

P2093

Cody P Coyne

http://www.w3.org/2001/XMLSchema#string

Lakshmi Narayanan

http://www.w3.org/2001/XMLSchema#string

P2860

Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2

Targeting CD19 in B-cell lymphoma: emerging role of SAR3419

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Epidermal growth factor-related peptides and their receptors in human malignancies

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

Immunosuppressive strategies that are mediated by tumor cells

Loss of CD20 and bound CD20 antibody from opsonized B cells occurs more rapidly because of trogocytosis mediated by Fc receptor-expressing effector cells than direct internalization by the B cells.

Differences in the intracellular distribution of acid-sensitive doxorubicin-protein conjugates in comparison to free and liposomal formulated doxorubicin as shown by confocal microscopy.

PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolites.

A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases.

P304

379-399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CBDD.12845

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27561602

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

molecular design

P932

5396302

http://www.w3.org/2001/XMLSchema#string